Pushkal Garg

EVP Chief R&D, Alnylam Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$5.4M

Companies

Latest trade

Mar 5, 2026

Companies

Alnylam Pharmaceuticals, Inc.EVP Chief R&D −$8.1M

Trades

ALNY Sold 2,404 shares at $323.96 · planned $0.8M Mar 5

ALNY Sold 2,309 shares at $323.08 · planned $0.7M Mar 4

ALNY Sold 1,775 shares at $319.74 · planned $0.6M Mar 3

ALNY Sold 1,717 shares at $327.66 · planned $0.6M Mar 2

ALNY Sold 4,627 shares at $331.34 · planned $1.5M Feb 27

ALNY Sold 2,242 shares at $310.08 $0.7M Feb 13

ALNY Sold 1,510 shares at $362.87 $0.5M Jan 12

ALNY Sold 3,022 shares at $451.48 · planned $1.4M Oct 3

ALNY Sold 2,937 shares at $452.05 · planned $1.3M Oct 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.